CLSD Clearside Biomedical Inc

Clearside Biomedical Inc is a clinical biopharmaceutical company. It is engaged in developing drug therapies to treat blinding diseases of the eye.

$3.16
As of 03/05/2021     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Micro cap
Health Care
Biotechnology
USA
USA
06/02/2016
48,353,952
553,547
$152,798,488
0.00%
SEC Edgar Online
10-Q
10-K
185063104
US1850631045
BZ6VT37

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-10.77
18.81
15.55
-174.72%
-144.47%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy